key: cord-0804296-pqtt14tj
authors: Althoff, Keri N; Laeyendecker, Oliver; Li, Rong; Coburn, Sally B; Klock, Ethan; Baker, Owen R; Quinn, Thomas C; Michael, Jeffrey; Shields, Wendy C; Ehsani, Johnathon; Thomas, F Dennis; Graham, Lindsey A; Ali, Zabiullah; Manabe, Yukari C; Li, Ling
title: SARS-CoV-2 antibody status in decedents undergoing forensic postmortem examination in Maryland, May 24 to June 30, 2020
date: 2020-12-15
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofaa611
sha: 41ae4dd74a4b94999dbcfc720656602c464889de
doc_id: 804296
cord_uid: pqtt14tj

Seroprevalence of SARS-CoV-2 antibodies was 10% among the subset of decedents undergoing forensic postmortem examination in June in Maryland. Decedents of motor vehicle crashes had similar seroprevalence compared to those with a natural death (including decedents with SARS-CoV-2 infection). Decedents of motor vehicle crashes may be a sentinel surveillance population.

M a n u s c r i p t

The first cases of COVID-19 in Maryland were confirmed on March 5, 2020 . A genomic analysis of SARS-CoV-2 patients receiving care in the Maryland, District of Columbia, and Virginia determined multiple introductions of the virus to the region. 1 The 7day average number of confirmed cases in Maryland peaked at 1,125 on May 25 and declined to 364 on June 30. 2 The daily positivity rate for SARS-CoV-2 RNA was higher for Latino patients seeking care at the Johns Hopkins Health System between March 11 and May 25, 2020, peaking at 53.4% on May 10 compared to 16.1% for White and 29.6% for Black patients. 3 A survey administered June 17-28 to 1,030 Marylanders found 55 (5.2%) had ever tested positive for SARS-CoV-2 RNA. 4 The proportion of individuals who have an immune response to SARS-CoV-2 provides information on the spread of infection. The largest seroprevalence study from 10 geographic sties in the US (not including Maryland) suggested 10 times more SARS-CoV-2 infections occurred than the number of confirmed cases. 5 Maryland Statue 5-309 mandates decedents undergo forensic postmortem examination by the Maryland Office of the Chief Medical Examiner (OCME) to determine cause and manner of death for those who died suddenly and unexpectedly, from non-natural causes, in police custody or with suspicious activity, with no physician attendant, and those who are homeless at death. 6 Individuals who survive long enough after a motor vehicle crash to have a description of injuries documented by medical professional may be waived from postmortem examination if no charge is pending. Decedents undergoing this examination may be underrepresented in general population seroprevalence studies.

The objective of this study was to estimate the seroprevalence of SARS-CoV-2 antibodies among decedents examined by the Maryland OCME from May 24 to June 30, 2020.

A c c e p t e d M a n u s c r i p t

The study population included all decedents undergoing forensic postmortem examination (including toxicology for drugs and alcohol) by the OCME from May 24 to June 30, 2020 from whom 5mL of whole blood could be collected. The Johns Hopkins Bloomberg School of Public Health internal review board (IRB) determined the study is not human subjects research and the Maryland Health Department IRB provided "exemption" status.

In April 2020, the Maryland OCME implemented a protocol that included questioning living Age at death, sex, race, Hispanic ethnicity, homelessness, cause and manner of death were abstracted from the OCME electronic database.

Covariates were compared by SARS-CoV-2 antibody status using student's t tests and

Fischer's exact chi square tests for differences in means and proportions (respectively). The prevalence of SARS-CoV-2 antibodies was estimated for each week during the study period.

The 7-day average number of new COVID-19 cases and the positivity rate in Maryland were A c c e p t e d M a n u s c r i p t plotted over the same period. 2, 8 Log binomial regression models estimated adjusted prevalence ratios (aPR) and 95% confidence intervals [,]; adjusted models include age (<60 and ≥60 years, sex (male and female), race (White, Black and Hispanic), homeless status, and manner and cause of death (natural, homicide, suicide, accidental illicit drug intoxication, accidental motor vehicle crash, other accident, undetermined, and manner is still pending).

Of the 720 decedents examined, 500 had a viable whole blood specimen for testing. There A c c e p t e d M a n u s c r i p t Although the population undergoing forensic post-mortem examination by the OCME may differ in lifestyle from those in general population seroprevalence studies, SARS-CoV-2 seroprevalence in this population reflected ethnicity patterns of COVID-19 burden reported in healthcare settings and surveys of testing in Maryland. 3, 4 Our reported seroprevalence of 10% is higher than that reported in seroprevalence studies prior to June 1 in the US outside of New York City. 5, [9] [10] [11] There may be a higher seroprevalence in decedents undergoing forensic examination due to shared risk factors for non-natural causes of death and COVID-19, such as socioeconomic disadvantage at the individual-and neighborhood-level. 12, 13 A c c e p t e d M a n u s c r i p t Decedents undergoing forensic investigation provide insight into populations that may be underrepresented in general population seroprevalence studies. We found a lower prevalence of SARS-CoV-2 antibodies in accidental illicit drug intoxication decedents compared to those who died of natural causes. Network studies among drug users have demonstrated smaller and stable personal networks (compared to larger networks) are protective against other infectious diseases, such as HIV. 14 As overdose deaths may be increasing during the US COVID-19 epidemic, data describing SARS-CoV-2 infection in drug users and the epidemic's impact on their networks are needed to understand syndemic potential. 15 Conversely, we found 23% (9/39) seroprevalence of SARS-CoV-2 antibodies in those who died from motor vehicle crashes; this seroprevalence was similar to those with a natural death (28% or 14/69), which included the 12 decedents who were found to be SARS-CoV-2 infected at the time of death via the OCME protocol. Given their high prevalence, motor vehicle crashes decedents may be a unique sentinel population for SARS-CoV-2 infection.

Limitations to our study include 96 decedents whose cause and manner of death are still pending. Of those with an undetermined manner of death, approximately half are illicit drugrelated deaths; the lower prevalence of SARS-CoV-2 antibodies among accidental illicit drug intoxication decedents is reflected in the undetermined group. Finally, other antibody tests (e.g., ELISA) may have produced different results. The rapid flow assay utilized has validated high sensitivity and specificity and is relatively cheap and easy to perform and has been compared to numerous ELISA assays for comparison of our results to forthcoming seroprevalence studies that utilize ELISAs. 7 Our study demonstrates 10% SARS-CoV-2 seroprevalence in decedents undergoing forensic postmortem examination and reflects ethnicity patterns of acute disease burden.

These decedents provided timely information and allowed for inclusion of those who may be underrepresented in general population seroprevalence studies. Our approach could be replicated among decedents in other locations.

A c c e p t e d M a n u s c r i p t

The Johns Hopkins Bloomberg School of Public Health internal review board (IRB) determined the study is not human subjects research and the Maryland Health Department IRB provided "exemption" status.

This study was performed in conjunction with a study of drug prevalence among fatally 

Genomic diversity of SARS-CoV-2 during early introduction to the United States National Capital Region. medRxiv Prepr

Maryland Coronavirus Map and Case Count. The New York Times

SARS-CoV-2 Positivity Rate for Latinos in the

Rapid real-time tracking of nonpharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse study. medRxiv Pre print2

Seroprevalence of Antibodies to SARS-CoV-2 in 10

Sites in the United States

United States: Annotated Code of Maryland. Health General. Title 5. Death

Evaluation of serological SARS-CoV-2 lageral flow assays for rapid point of care testing

Coronavirus disease 2019 (COVID-19) Outbreak. 2020. Available at

COVID-19 Antibody Seroprevalence

Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City

Seroprevalence of SARS-CoV-2-Specific Antibodies among Adults

Trends in socioeconomic inequalities in motor vehicle accident deaths in the United States

Prevalence of Comorbidities and Risks Associated with COVID-19 Among Black and Hispanic Populations in New York City: an Examination of the 2018 New York City Community Health Survey. J Racial Ethn Heal Disparities

Alter A, Yeager C. COVID-19 Impact on US National Overdose Crisis. Ovedose Detection Mapping Application Program

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t Footnotes: The 7-day average (average of the specified day and the previous 6 days) number of confirmed cases in Maryland was estimated by The New York Times coronavirus database, available at https://www.nytimes.com/interactive/2020/us/maryland-coronavirus-cases.html. The 7-day average testing positivity in Maryland was from the Maryland Department of Health, available at https://coronavirus.maryland.gov/.A c c e p t e d M a n u s c r i p t